期刊文献+

药物临床试验不良反应因果关系评价方法概述与存在问题的思考 被引量:10

Overview of causality evaluation methods for adverse reactions in drug clinical trials and consideration of existing problems
原文传递
导出
摘要 目前,国际上对于临床试验期间的药物不良反应因果关系评价方法尚无统一标准,在实际工作中存在诸多问题与挑战。本文通过检索国内外文献,介绍了5种国内外较常用的因果关系评价方法和我国上市后药物不良反应因果关系判断法,对当前临床试验期间药物不良反应因果关系判定存在问题进行分析及探讨。 At present,there is no unified international standard for the causality assessment method of adverse reactions during clinical trials,and there are many problems and challenges in practical work.Through searching domestic and foreign literature,this paper introduced 5 commonly used methods of causality assessment at home and abroad and the judgment method of causality of adverse reactions after marketing in China,analyzed and discussed the existing problems in the determination of causality of adverse reactions during current clinical trials.
作者 刘敏 王海学 LIU Min;WANG Hai-xue(Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2023年第8期1206-1211,共6页 The Chinese Journal of Clinical Pharmacology
关键词 临床试验 不良事件 药物不良反应 因果关系 安全性评价 clinical trial adverse events adverse reactions causality safety evaluation
  • 相关文献

参考文献15

二级参考文献128

  • 1杜文民,王永铭,程能能.药品不良反应的判定与其研究方法(续完)[J].中国药物警戒,2005,2(1):11-13. 被引量:27
  • 2杜文民,王永铭,程能能.药物不良反应的判定与其研究方法(续一)[J].中国药物警戒,2004,1(2):17-20. 被引量:16
  • 3马彬,杨克虎,刘雅莉,田金徽,张仲男,李幼平,王莉,徐莉,曹晓源,滕永军,王羽,张宗久,赵明钢,陆君,柳琪林.英国医疗风险监管体系的循证评价及其对我国医疗风险管理的启示——关注病人安全,预防医疗差错,提高医疗质量[J].中国循证医学杂志,2006,6(7):514-522. 被引量:41
  • 4黄宇虹,张伯礼.单一事件药物不良反应的因果关系评价[J].中国临床药理学与治疗学,2007,12(6):697-699. 被引量:4
  • 5International Conference on Harmonization on Technical Requirements of Pharmaceuticals for Human Use.Topic 2A Note for Guidance on Clinical Safety Data Management:Definitions and Standards for Expedited Reporting,CPMP/[CH/377/95[M].London:Buropcan Agency for the Evaluation of Medicinal Products,1994.
  • 6CIOMS Working Group V.Current Challenges in Pharmacovigilance:Pragmatic Approaches:Report of CIOMS Working Group V[R].Council for International Organizations of Medical Sciences,Geneva,2001.
  • 7International Conference on Harmonization on Technical Requirements of Pharmaceuticals for Human Use.Topic 2A Note for Guidance on Clinical Safety Data Management:Definitions and Standards for Expedited Reporting,CPMP/ICH/377/95[R].London:European Agency for the Evaluation of Medicinal Products,1994.
  • 8WHO.Adverse Reaction Terminology Critical Term List,WHO Collaborating Center for International Drug Monitoring,Uppsala,Sweden[EB/OL].[2009-02-02].http//www.who-umc.org.
  • 9Shakir SAW.Causality and correlation in pharmacovigilance.In:Talbot J,Waller P(ed).Stephens'Detection of New Adverse Drug Reactions[J].2004(5):329-343.
  • 10Meyboom R H B,Hekster Y A,Egberts A C G,et al.Causal or Casual?The role of causality assessment in pharmacovigilance[J].Drug Safety 1997;17(6):374-389.

共引文献702

同被引文献90

引证文献10

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部